Clovis Oncology Inc (Inactive Symbol)

YTD Price Probability

No random walk data for 2024

Default prediction by Z-Score (what's this?).

Z Score :

-0.6531

Sector

Industry

View the other companies in the same industry : Bio Therapeutic Drugs

Alternative Z-Scores designed for non-public companies (i.e. take these with a grain of salt):

For manufacuring companies:

Z' Score :

-0.1166

Sector Industry

For non-manufacturing companies:

Z'' Score :

-1.0405

Sector Industry

Fundamental Analysis metrics & ratios (what's this?).

Date of financial statements used: 2017-03-31
Book Value:	$95.5M	Internal Value:	$95.5M	Working Capital:	$369.9M
Debt to Asset Ratio:	0.675	Current Ratio:	7.284	Turnover Ratio:	4.332
Net Margin:	-830.4%	EPS:	-6.074	P/E ratio:	-7.837
P/B ratio:	19.188	ROE:	-244.8%	ROA:	-43.6%

Symbol: CLVS

Market Cap: $1.8B

Exchange: NASDAQ

Data Since: 2012-01-03